Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-18 | The following table sets forth the name, age and positions of each Director Nominee: Robert A. Cascella 67 Director Nominee. No committees or compensation details provided. |
| 2023-03-29 | Robert A. Cascella Former CEO of Precision Diagnostics, Royal Phillips Age 68 Committee Membership: AC (Chair) Annual Compensation: $50,481 |
| 2024-03-28 | Robert A. Cascella Audit Committee Chair Cash Retainer $65,000 Common Stock Award $60,000 Total $125,000 Committee Membership: Audit Committee Chair |
| 2025-04-04 | Over more than 30 years, Mr. Cascella has supported value creation in the healthcare industry, with a strong focus on innovation and integrated solutions. Mr. Cascella retired from Philips on December 31, 2021, after working for the company since 2015. The last position he held before retiring was Executive Vice President and Strategic Business Development Leader and was also a member of the company’s Executive Committee. Prior to that role, Mr. Cascella was the CEO for the Precision Diagnosis Segment, responsible for the integration of smart systems, software, informatics and services dedicated to delivering on the promise of precision medicine. Prior to that role, Mr. Cascella was the CEO of the Diagnosis and Treatment Segment, where he was responsible for the development and growth of modality-based diagnostics and interventional treatment and therapy. Before joining Philips, Mr. Cascella spent 11 years at Hologic, a global leader in Women’s Health, as its president, and later, its CEO. Under his leadership, Hologic broadly diversified its product portfolio and substantially grew revenues through a combination of innovative product development and acquisition, as well as the building of strong customer relationships. Mr. Cascella serves as a board director for Celestica (NYSE: CLS), Mirion Technologies (NYSE: MIR) and Neuronetics (Nasdaq: STIM). He is also a NACD certified director. Mr. Cascella holds a Bachelor of Arts in accounting from Fairfield University. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-14 | Mr. Cascella holds a Bachelor of Arts in accounting from Fairfield University. The Board believes Mr. Cascella’s financial and managerial experience as CEO of a publicly traded medical technology company, as well as his experience serving on the board of directors of other companies qualifies him to serve as a director on the Board. |
| 2022-04-14 | Mr. Cascella holds a Bachelor of Arts in accounting from Fairfield University. |
| 2023-04-13 | Mr. Cascella was CEO for the Precision Diagnosis Segment at Philips, responsible for integration of smart systems, software, informatics and services, but no direct mention of programming or technical degrees. |
| 2024-04-11 | Mr. Cascella retired from Philips on December 31, 2021, after working for the company since 2015. The last position he held before retiring was Executive Vice President and Strategic Business Development Leader and was also a member of the company’s Executive Committee. Prior to that role, Mr. Cascella was the CEO for the Precision Diagnosis Segment, responsible for the integration of smart systems, software, informatics and services dedicated to delivering on the promise of precision medicine. ... Mr. Cascella holds a Bachelor of Arts in accounting from Fairfield University. |
Data sourced from SEC filings. Last updated: 2026-02-03